The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 13, 2019

Filed:

Apr. 09, 2018
Applicant:

Entasis Therapeutics Limited, Altrincham, GB;

Inventors:

Boudewijn Lodewijk Maria DeJonge, Waltham, MA (US);

Thomas Francois Durand-Reville, Belmont, MA (US);

Jeroen Cunera Verheijen, Westborough, MA (US);

Ruben Tommasi, Stow, MA (US);

John Mueller, Waltham, MA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/439 (2006.01); C07D 471/08 (2006.01); A61K 31/197 (2006.01); A61K 31/407 (2006.01); A61K 31/43 (2006.01);
U.S. Cl.
CPC ...
A61K 31/439 (2013.01); A61K 31/197 (2013.01); A61K 31/407 (2013.01); A61K 31/43 (2013.01); C07D 471/08 (2013.01);
Abstract

The present invention is directed to combinations of a β-lactamase inhibitor with sulbactam and, optionally, imipenem/cilastatin. The combinations are useful for the treatment of bacterial infections, including infections caused by drug resistant organisms, including multi-drug resistant pathogens. More particularly, the invention relates to a combination of β-lactamase inhibitor compound 1: or a pharmaceutically acceptable salt thereof, with sulbactam, or a pharmaceutically acceptable salt thereof, and, optionally, imipenem/cilastatin, or a pharmaceutically acceptable salt thereof.


Find Patent Forward Citations

Loading…